Simone Albisinni

Dec 19, 2024 | ejso.com | Simone Albisinni |Luca Orecchia |Georges Mjaess |Fouad Aoun |Francesco Del Giudice |Luca Antonelli | +10 more

Review ArticleArticles in Press109543 1Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy 2Department of Urology, Hopital Universitaire de Bruxelles, Universite’ Libre de Bruxelles, Bruxelles, Belgium 3Faculty of Medicine, Hôtel-Dieu de France, Saint-Joseph University, Beirut, Lebanon 4Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy 5Department of Urology, Kantonsspital Luzern, Lucerne,...

Jun 10, 2024 | nature.com | Luca Orecchia |Georges Mjaess |Simone Albisinni

Robot-assisted radical prostatectomy (RARP) has achieved the status of preferred surgical technique for prostate cancer (PCa) treatment in numerous healthcare settings worldwide [1]. The steadfast standardisation of the operative steps, coupled with a focused enhancements in patient recovery protocols, has improved surgical outcomes and has consistently reduced the length of stay (LOS). High volume meta-analyses have consistently shown low rates of major postoperative complications [2, 3].

May 30, 2024 | nature.com | Andrea Mari |Anna Cadenar |Simone Albisinni |Riccardo Autorino |Fabrizio Di Maida |M. Carmen Mir | +6 more

AbstractPositron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) is notable for its superior sensitivity and specificity in detecting recurrent PCa and is under investigation for its potential in pre-treatment staging. Despite its established efficacy in nodal and metastasis staging in trial setting, its role in primary staging awaits fuller validation due to limited evidence on oncologic outcomes.

Oct 26, 2023 | nature.com | Simone Albisinni

Editorial comment to “Relative Impact of Lymph-node Metastasis and Seminal Vesical Invasion on Oncologic Outcomes Following Radical Prostatectomy” PCAN 2023. Locally advanced prostate cancer with pathological seminal vesicle invasion (pT3b) is a very high-risk disease associated with worse outcome and is considered difficult to cure by radical prostatectomy alone [1]. However, the ideal protocol for additional therapy (adjuvant or salvage) is still debated [2].

Jul 16, 2023 | pubmed.ncbi.nlm.nih.gov | Simone Albisinni

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software